Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
Jazz Pharmaceuti
cals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
cals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.